Evaluation of White Blood Cell- and Platelet-Derived Cytokine Accumulation in MIRASOL-PRT-Treated Platelets
- 4 March 2009
- journal article
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 36 (2) , 114-120
Abstract
Background: Soluble mediators in platelet concentrates (PCs) released from contaminating white blood cells (WBCs) and platelets (PLTs) themselves are supposed to promote allergic and non-hemolytic febrile transfusion reactions in the recipient. Pathogen reduction technologies (PRTs) prevent replication and proliferation of pathogens as well as of WBCs, and may reduce cytokine accumulation in PCs during storage and prevent adverse events after PLT transfusion. On the other hand, such treatments may also lead to increased cytokine production by stimulation of WBCs or PLTs due to the photochemical or photodynamical process itself. Material and Methods: 12 triple-dose PLT apheresis collections were leukoreduced by the process-controlled leukoreduction system of the Trima Accel machine and split into 3 units undergoing Mirasol-PRT treatment (M) or gamma irradiation (X) or remaining untreated (C). During storage for up to 7 days, PLT activation, WBC-derived Th-1/2, and inflammatory as well as PLT-derived cytokines were measured by cytometric bead array and enzymelinked immunosorbent assay, respectively. Results: Independent of treatment, all PLT products exhibited low levels of WBC-associated cytokines near or below assay detection limits. WBC-associated cytokines were not elevated by Mirasol-PRT treatment. PLT-derived cytokines were detected at higher levels and increased significantly during storage in all units. Most likely due to higher PLT activation, M units showed significantly higher levels of PLT-derived cytokines compared to untreated and gamma-irradiated units on day 5 of storage. Conclusion: In all PCs, PLTs themselves were the main source of cytokine release. Mirasol-PRT treatment was associated with a significantly increased PLT activation and accumulation of PLT-derived cytokines during storage, without affecting WBC-derived cytokines relative to controls.Keywords
This publication has 28 references indexed in Scilit:
- The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBCTransfusion, 2004
- Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreductionTransfusion, 2004
- Storage of platelets in additive solutions: the effects of magnesium and potassium on the release of RANTES, β‐thromboglobulin, platelet factor 4 and interleukin‐7, during storageVox Sanguinis, 2003
- The influence of platelet additive solutions on cytokine levels and complement activation in platelet concentrates during storageVox Sanguinis, 2003
- Platelet concentrates derived from buffy coat and apheresis: biochemical and functional differencesTransfusion Medicine, 2002
- Evidence for de novo synthesis of cytokines and chemokines in platelet concentratesVox Sanguinis, 2002
- Febrile and allergic transfusion reactions after the transfusion of white cell‐poor platelet preparationsTransfusion, 1999
- Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor‐β1 in apheresis platelet concentrates during storageTransfusion, 1999
- A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to plateletsTransfusion, 1999
- The effect of chloramphenicol and cycloheximide on platelet aggregation and protein synthesisBiochemical Pharmacology, 1987